Seventeen cases of invasive aspergillosis occurring since 1987 in apparently immunologically normal hosts have been reviewed: 9 of invasive sinus aspergillosis, 2 of isolated brain abscesses, 3 of pneumonia (1 in a patient who developed mediastinitis), 2 of lymph node aspergillosis, and 1 of osteomyelitis of the foot. Two of the 9 patients with sinus aspergillosis died; the rest were stable up to March 1993. They responded initially to combined surgical and medical therapy. Both patients with brain abscesses survived following surgery, but one had neurological sequelae. Both patients with pneumonia were well following therapy with amphotericin B; one also received itraconazole. The patient with mediastinitis died, but this disease was diagnosed late. The patients with lymph node involvement were lost to follow-up, as was the patient with osteomyelitis. Invasive aspergillosis may be common in Pakistan. Greater awareness would allow earlier diagnosis and therapy, thereby improving the outcome.
were female and eight were male. All patients with aspergillar sinusitis (cases 1-9) had a long history of rhinitis (figure 1). One patient with pulmonary aspergillosis (case 12) had a long history of asthma and also had a history of treated tuberculosis. Another patient (case 13) had fibrotic changes evident on a chest radiograph that were suggestive of pulmonary tuberculosis, as did patients 2, 3, 7, and 11. In one patient (case 16), tuberculosis was suspected; however, there was no response to antituberculosis therapy, all mycobacterial cultures were negative, and the patient had mediastinal involvement with Aspergillus fumigatus. 14 and 15) (figure 2) . In one case (case 14), interstitial pulmonary fibrosis evident on a chest radiograph suggested underlying sarcoidosis. Levels of angiotensin-converting enzymes were not elevated, however. The patient was lost to follow-up, but during hospitalization no other evidence of immunosuppression was noted, i.e., a history of recurrent infections or the presence of oral thrush on examination. Bacterial and mycobacterial cultures of sputum and lymph nodes were negative.
Two patients presented with lymph node aspergillosis (cases
In the second case (case 15), chest radiographic findings were suggestive of aspergillar pneumonia. Bacterial and mycobacterial cultures of sputum and lymph nodes were negative. Lymph node cultures yielded only A. fumigatus. Two patients (cases 10 and 11) had isolated brain abscesses ( figure 3) . No pulmonary or other source was detected. From the single patient with osteomyelitis of the foot (case 17), A. fumigatus was isolated; no other system appeared involved.
Figure 1. A CT scan (direct coronal section) revealed an inflammatory mass in the sphenoid sinus and posterior aspect of the left maxillary antrum, with destruction of its lateral wall, in this patient with aspergillosis (case 8).
Laboratory Tests WBC counts ranged from 6,500/mm3 to 26,300/mm3, with a mean of 11,165/mm3. Differential counts were available for all patients (table 1) except in cases 5 and 17. In the cases in which the erythrocyte sedimentation rate was available, it was not markedly elevated, except in case 15, in which it was 131 mm/h. Renal and liver function tests were not performed for all patients, as they otherwise appeared well, without stigmata of liver or renal disease. When these tests were performed, the results were normal (table 1).
Immunologic Parameters
HIV testing was negative in cases 12 and 15 but was not performed in the other cases. Results of nitroblue tetrazolium tests and neutrophil chemotaxis studies were also normal for these two patients. In case 15 serum protein immunoelectrophoresis demonstrated an elevated level of IgG, but otherwise the findings were normal.
Outcome

Two patients with intracranial extension of sinus aspergillosis died despite aggressive combined surgical and medical therapy with up to 3 g of amphotericin B. Patient 2 had received only 250 mg of amphotericin when she died of postoperative complications. All other patients with invasive sinus disease required further follow-up, as residual disease and recurrent disease were common. However, none had developed recurrent infections, oral thrush, or lymphadenopathy or had evidence of renal or liver disease on follow-up. Patient 12, who had asthma and pneumonia, did not respond to up to 3 g of amphotericin B and developed new pulmonary infiltrates. Considerable improvement was noted following therapy with a 200 mg/d dosage of itraconazole (figure 4). Case 16 was misdiagnosed as tuberculosis. Only after 6 months of ineffective therapy did a mediastinal biopsy yield an Aspergillus species. The patient had received 100 mg of amphotericin B when he died of massive hemoptysis soon after surgery.
The two patients with isolated brain abscesses did well after surgery and adjuvant therapy with amphotericin B. The patients with lymph node aspergillosis and osteomyelitis were lost to follow-up. developed world [32] . One patient was a Sudanese and the second a patient from Zambia. In both of these cases, as well as those reported from the Sudan and Although A. fumigatus has been described as the most common cause of aspergillosis, A. flavus is more common in invasive disease, particularly in lesions beginning in the paranasal sinuses [33] [34] [35] [36] [37] . Aspergillar meningitis often is due to extension of aspergillar sinusitis, resulting in chronic basilar meningitis [38] . Cultures are usually negative. In one patient with sinus disease (case 2), initial CSF analysis demonstrated an elevated cell count and protein level.
Discussion
Invasive Aspergillus in immunocompromised hosts is well documented, and the species is second only to Candida species as an opportunistic fungal pathogen [14, 15]. Conditions known to predispose to invasion include qualitative or quantitative neutrophil defects; cytotoxic drug, corticosteroid, or prolonged antibiotic administration; and possibly underlying lung disease and cell-mediated immune dysfunction related
hosts has previously been described (particularly as sinusitis and pulmonary disease). Allergic responses to the fungus appear to play a significant role in pathogenesis. Patients with allergic sinusitis, initially described by Katzenstein et al. [21], and bronchopulmonary aspergillosis are increasingly reported in the literature. Allergic reactions also occur in patients with aspergillar infection in their paranasal sinuses or ectatic bronchi [21, 22]. Perhaps less well-recognized is the development of invasive aspergillosis in such patients. A certain subset of patients with no other evident risk factors go on to develop invasive sinus or pulmonary disease after several months or years [23-30]. Almost all of our patients with invasive sinus disease were atopic and had long histories of allergic rhinitis and nasal polyps (table 1). In addition, one of our patients with invasive pulmonary disease had a long history of asthma. However, atopy was not specifically mentioned in several of the largest series of invasive sinusitis reported from the Sudan, where heavy environmental exposure was thought to be causative. Described patients in the Sudan were usually asymptomatic and presented with unilateral proptosis of gradual progression over months [31]. Our patients all had headache, most complained of intermittent fever and nasal discharge for months before presenting, and several had had nasal polypectomies or other surgery (table 1, cases 1-9). Two cases of intracranial extension of paranasal sinus aspergillosis over a 10-year period in the Birmingham area of England were noted by Oates et al., an interval reflecting how rare the condition is in the
We have described two cases of isolated brain abscesses.
Intracranial abscesses without other apparent sources may follow intravenous drug abuse or occur sporadically via hematogenous spread from an occult, probably pulmonary, source. More commonly, CNS involvement occurs by direct extension of invasive aspergillar infection and may follow head trauma [39-41]. In our patients there was no evidence of direct invasion and no history of intravenous drug use.
Karam and Griffin reviewed invasive pulmonary aspergillosis in immunocompetent hosts [5] . Among 25 patients with definite invasive pulmonary disease, 4 had a history of alcohol-ism, 3 had a history of influenza A, and only 1 had a history of asthma; 46.9% of patients were apparently healthy. Antecedent viral infection was not noted in our patients who reported prolonged symptoms at presentation.
An asthmatic patient with no history of steroid use developed extensive pulmonary aspergillosis after resection of an aspergilloma (case 12). In a previously reported case [9] , disseminated aspergillosis involving the myocardium and brain occurred after resection of an aspergilloma. This patient, however, had a history of alcohol and drug use as well as tuberculosis, and the clinical condition rapidly deteriorated until death occurred on the 28th postoperative day; this contrasts with the more indolent presentation of our case 12.
Alcohol use may induce neutrophil dysfunction sufficiently enough to predispose a patient to invasiveaspergillosis [42] . None of our patients reported alcohol or drug use. Alcohol use is uncommon in Pakistan, and significant renal or liver disease was not noted in our patients.
Aspergillar infection of the lymph nodes is uncommon, occurring with dissemination and in chronic granulomatous disease [43] . We have described two patients from whom Aspergillus species were recovered by culture of lymph node specimens (cases 14 and 15); pathology demonstrated granuloma formation (figure 2). In one series of 64 granulomatous lymph nodes, Aspergillus species were not identified [44] . Granulomas were initially noted in one of our patients (case 14); later cultures of the lymph node yielded A. flavus. In the second patient (case 15), an 8-year-old girl, the findings of several nitroblue tetrazolium reduction tests made the presence of underlying chronic granulomatous disease, which is known to predispose to invasive aspergillosis, less likely. Eosinophilia was not noted in our patients.
Mediastinal invasion with Aspergillus species is extremely rare [45] but occurred in one of our patients (case 16). He had initial pneumonia and empyema unresponsive to antituberculosis therapy; all bacterial and mycobacterial cultures remained negative. Subsequent mediastinoscopy and biopsy demonstrated hyphae, and cultures yielded A. fumigatus. The etiology of granulomatous mediastinitis is not established in most instances; a review of 77 patients proved that only for 3 (2 with histoplasmosis and 1 with tuberculosis) could the responsible organism be determined [46] .
Pulmonary aspergillosis followed tuberculosis in two of our patients. In an adult asthmatic (case 12), an aspergilloma occurred in a presumptive tuberculous cavity. The patient had a history of response to antituberculosis therapy. In an 8-year-old girl, tuberculosis was evident on a chest radiograph before she presented with an empyema, which subsequently yielded an Aspergillus species. Underlying lung disease has been described as a predisposing factor for invasive aspergillosis [17, 18] . It is difficult to exclude associated phagocytic impairment as a factor in the setting of tuberculosis. Several other patients (cases 2, 3, 7, and 11) had evidence of old, probably healed tuberculosis on chest radiographs. In summary, the majority of patients described had underlying abnormalities in the areas of involvment, which probably predisposed to colonization with Aspergillus species before invasive disease set in.
The pathology of invasive aspergillosis depends on the host. As has been described with regard to immunocompetent patients, granuloma with multinucleated giant cells is the predominant histopathologic feature. This was seen in our patients (figure 2) and has been noted in the literature. Vascular invasion usually occurs in immunocompromised patients [47] . Gefter et al. [47] have previously reported a chronic cavitary form of pulmonary aspergillosis that may occur with mild immunosuppression or underlying lung disease. They referred to this form as "semiinvasive." The pathology is distinct: extensive lung destruction can occur despite the lack of vascular invasion [48] . [38] . Dense concretions within a paranasal sinus mass are said to be pathognomonic of an aspergillar granuloma [49] . MRI may be superior; aspergilloma is distinctive in returning a very low T2 signal, attributed to the high content of iron and manganese in fungal tissue [50] . In invasive pulmonary aspergillosis, a CT halo or multiple small inflammatory masses may be seen [51, 52] . Gefter et al. described the radiographic spectrum of "semiinvasive aspergillosis" as early pulmonary consolidation and pleural thickening; as cavitation develops, a "crescent sign" may be seen [48] .
CT and MRI are important noninvasive methods for evaluating invasive fungal disease. The CT appearance of intracranial aspergillosis may be nonspecific and may contribute to the difficulty in diagnosis. Beal et al. described low-attenuation lesions showing variable degrees of contrast-enhanced mass effect
The best chemotherapeutic approach to chronic necrotizing pulmonary aspergillosis is not known, but intravenous amphotericin B is effective [53] . Herbert and Bayer stressed the wide strain-to-strain variability in susceptibility to amphotericin B in vitro and the higher minimal fungistatic concentrations of A. flavus as compared with those of A. fumigatus [47] . However, correlation between in vitro susceptibility and in vivo response does not always occur [53] .
Denning et al. noted that for 35% of Aspergillus isolates tested, the MIC of amphotericin was >4 ,ug/mL, a level usually considered resistant. Eighteen of 21 patients evaluated responded to itraconazole [54] . In our case 12, a patient with pulmonary aspergillosis, clearing of pulmonary infiltrates occurred after therapy for itraconazole. In a subsequent review of 2,121 cases of therapy for invasive aspergillosis [55] , Denning and Stevens noted an overall response rate of 55% to amphotericin B. In one series, the conditions of several patients with apparent chronic necrotizing pulmonary aspergillosis failed to improve with intravenous amphotericin B therapy but responded to intracavitary amphotericin B [55] .
Surgical treatment alone appeared satisfactory for the majority of nonimmunocompromised patients with aspergillar sinusitis, specifically maxillary sinusitis. However, surgical and medical therapy failed in three cases, of which two involved sphenoid sinus disease. Other patients with sphenoid disease did well with surgery alone [56, 57] . In the series reported from the Sudan, most patients responded to surgery [31] . All our patients with sinus disease required repeated and extensive surgery, as well as therapy with amphotericin B. Two of these nine patients (table 1) died, one was lost to follow-up, and several others had residual disease.
In 33 assessable cases of cerebral aspergillosis, mostly involving immunocompromised patients, Denning and Stevens [55] noted an overall 24% response to therapy; mortality was nearly 100% among immunocompromised patients. Our patients with isolated brain abscesses (cases 10 and 11) survived after surgery, although one had severe neurological sequelae, as noted in previous cases [38] [39] [40] [41] . Surgery alone may be adequate for well-encapsulated single lesions in less immunocompromised patients.
Bone aspergillosis often follows trauma or surgery, as in one of our patients. The patient required repeated surgery over several months, as well as therapy with amphotericin B. Secondary infection with invasive Aspergillus in a previously infected foot cannot be excluded. As suggested in the literature, combined medical and surgical therapy is indicated. Among responders in one series, 59% underwent a combination of medical and surgical therapy [58] .
Although immunologic data were not available for most of our patients, no clinical evidence of immunosuppression was noted during presentation or in subsequent follow-up visits in patients who were available for follow-up. HIV testing was not done, except in cases 12 and 15. AIDS is present in Pakistan; the World Health Organization had reported 52 cases as of May 1995. However, invasive aspergillosis is not common in patients with AIDS [59] . In a literature review, additional and known predisposing risk factors for invasive aspergillosis-i.e., neutropenia, corticosteroid use, or intravenous drug use-were noted in 79% of cases involving HIV-infected patients.
The frequency of cases presenting to the Aga Khan University Hospital appears unusual. As suggested, several factors may be responsible, including the susceptibility of hosts with subtle phagocytic defects from occult liver disease, tuberculosis, atopy, or other possible unknown socioeconomic factors. The description of a selective neutrophil defect in eradication of Aspergillus species suggests that other specific unidentified factors may be required for killing this fungus [60, 61] . In addition, a more virulent subtype of Aspergillus or heavy environmental exposure may be responsible. Recognition of the increased prevalence of invasive aspergillosis is necessary in developing countries, where facilities for isolation of Aspergillus species may not be readily available.
